Keren Ladin1, Renuka Pandya2, Allison Kannam2, Rohini Loke2, Tira Oskoui2, Ronald D Perrone3, Klemens B Meyer3, Daniel E Weiner3, John B Wong3. 1. Department of Occupational Therapy, Tufts University, Medford, MA; Research on Aging, Ethics, and Community Health, Tufts University, Medford, MA. Electronic address: keren.ladin@tufts.edu. 2. Research on Aging, Ethics, and Community Health, Tufts University, Medford, MA. 3. Department of Medicine, Tufts Medical Center, Boston, MA.
Abstract
BACKGROUND: Although dialysis may not provide a large survival benefit for older patients with kidney failure, few are informed about conservative management. Barriers and facilitators to discussions about conservative management and nephrologists' decisions to present the option of conservative management may vary within the nephrology provider community. STUDY DESIGN: Interview study of nephrologists. SETTING & PARTICIPANTS: National sample of US nephrologists sampled based on sex, years in practice, practice type, and region. METHODOLOGY: Qualitative semistructured interviews continued until thematic saturation. ANALYTICAL APPROACH: Thematic and narrative analysis of recorded and transcribed interviews. RESULTS: Among 35 semistructured interviews with nephrologists from 18 practices, 37% described routinely discussing conservative management ("early adopters"). 5 themes and related subthemes reflected issues that influence nephrologists' decisions to discuss conservative management and their approaches to these discussions: struggling to define nephrologists' roles (determining treatment, instilling hope, and improving patient symptoms), circumventing end-of-life conversations (contending with prognostic uncertainty, fearing emotional backlash, jeopardizing relationships, and tailoring information), confronting institutional barriers (time constraints, care coordination, incentives for dialysis, and discomfort with varied conservative management approaches), conservative management as "no care," and moral distress. Nephrologists' approaches to conservative management discussions were shaped by perceptions of their roles and by a common view of conservative management as no care. Their willingness to pursue conservative management was influenced by provider- and institutional-level barriers and experiences with older patients who regretted or had been harmed by dialysis (moral distress). Early adopters routinely discussed conservative management as a way of relieving moral distress, whereas others who were more selective in discussing conservative management experienced greater distress. LIMITATIONS: Participants' views are likely most transferable to large academic medical centers, due to oversampling of academic clinicians. CONCLUSIONS: Our findings clarify how moral distress serves as a catalyst for conservative management discussion and highlight points of intervention and mechanisms potentially underlying low conservative management use in the United States.
BACKGROUND: Although dialysis may not provide a large survival benefit for older patients with kidney failure, few are informed about conservative management. Barriers and facilitators to discussions about conservative management and nephrologists' decisions to present the option of conservative management may vary within the nephrology provider community. STUDY DESIGN: Interview study of nephrologists. SETTING & PARTICIPANTS: National sample of US nephrologists sampled based on sex, years in practice, practice type, and region. METHODOLOGY: Qualitative semistructured interviews continued until thematic saturation. ANALYTICAL APPROACH: Thematic and narrative analysis of recorded and transcribed interviews. RESULTS: Among 35 semistructured interviews with nephrologists from 18 practices, 37% described routinely discussing conservative management ("early adopters"). 5 themes and related subthemes reflected issues that influence nephrologists' decisions to discuss conservative management and their approaches to these discussions: struggling to define nephrologists' roles (determining treatment, instilling hope, and improving patient symptoms), circumventing end-of-life conversations (contending with prognostic uncertainty, fearing emotional backlash, jeopardizing relationships, and tailoring information), confronting institutional barriers (time constraints, care coordination, incentives for dialysis, and discomfort with varied conservative management approaches), conservative management as "no care," and moral distress. Nephrologists' approaches to conservative management discussions were shaped by perceptions of their roles and by a common view of conservative management as no care. Their willingness to pursue conservative management was influenced by provider- and institutional-level barriers and experiences with older patients who regretted or had been harmed by dialysis (moral distress). Early adopters routinely discussed conservative management as a way of relieving moral distress, whereas others who were more selective in discussing conservative management experienced greater distress. LIMITATIONS: Participants' views are likely most transferable to large academic medical centers, due to oversampling of academic clinicians. CONCLUSIONS: Our findings clarify how moral distress serves as a catalyst for conservative management discussion and highlight points of intervention and mechanisms potentially underlying low conservative management use in the United States.
Authors: Rachael L Morton; Paul Snelling; Angela C Webster; John Rose; Rosemary Masterson; David W Johnson; Kirsten Howard Journal: CMAJ Date: 2012-02-06 Impact factor: 8.262
Authors: Allison Tong; Katharine L Cheung; Sumi Sukumaran Nair; Manjula Kurella Tamura; Jonathan C Craig; Wolfgang C Winkelmayer Journal: Am J Kidney Dis Date: 2014-01-07 Impact factor: 8.860
Authors: Mae Thamer; James S Kaufman; Yi Zhang; Qian Zhang; Dennis J Cotter; Heejung Bang Journal: Am J Kidney Dis Date: 2015-06-26 Impact factor: 8.860
Authors: Tim Luckett; Marcus Sellars; Jennifer Tieman; Carol A Pollock; William Silvester; Phyllis N Butow; Karen M Detering; Frank Brennan; Josephine M Clayton Journal: Am J Kidney Dis Date: 2014-01-14 Impact factor: 8.860
Authors: Melissa W Wachterman; Edward R Marcantonio; Roger B Davis; Robert A Cohen; Sushrut S Waikar; Russell S Phillips; Ellen P McCarthy Journal: JAMA Intern Med Date: 2013-07-08 Impact factor: 21.873
Authors: Fahad Saeed; Susan A Ladwig; Ronald M Epstein; Rebeca D Monk; Paul R Duberstein Journal: Clin J Am Soc Nephrol Date: 2020-06-04 Impact factor: 8.237
Authors: Claire A Richards; Chuan-Fen Liu; Paul L Hebert; Mary Ersek; Melissa W Wachterman; Lynn F Reinke; Leslie L Taylor; Ann M O'Hare Journal: Clin J Am Soc Nephrol Date: 2019-08-29 Impact factor: 8.237
Authors: Susan P Y Wong; Saritha Boyapati; Ruth A Engelberg; Bjorg Thorsteinsdottir; Janelle S Taylor; Ann M O'Hare Journal: Am J Kidney Dis Date: 2019-09-27 Impact factor: 8.860
Authors: Sarah J Ramer; Nicolas A Baddour; Edward D Siew; Huzaifah Salat; Aihua Bian; Thomas G Stewart; Susan P Y Wong; Manisha Jhamb; Khaled Abdel-Kader Journal: Am J Nephrol Date: 2020-07-28 Impact factor: 3.754
Authors: Sarbjit V Jassal; Maria Larkina; Kitty J Jager; Fliss E M Murtagh; Ann M O'Hare; Norio Hanafusa; Hal Morgenstern; Friedrich K Port; Keith McCullough; Ronald Pisoni; Francesca Tentori; Rachel Perlman; Richard D Swartz Journal: CMAJ Date: 2020-08-31 Impact factor: 8.262
Authors: Keren Ladin; Renuka Pandya; Ronald D Perrone; Klemens B Meyer; Allison Kannam; Rohini Loke; Tira Oskoui; Daniel E Weiner; John B Wong Journal: Clin J Am Soc Nephrol Date: 2018-07-26 Impact factor: 8.237
Authors: Nwamaka D Eneanya; Shananssa G Percy; Taylor L Stallings; Wei Wang; David J R Steele; Michael J Germain; Jane O Schell; Michael K Paasche-Orlow; Angelo E Volandes Journal: Am J Nephrol Date: 2020-08-13 Impact factor: 3.754
Authors: Susan P Y Wong; Lynne V McFarland; Chuan-Fen Liu; Ryan J Laundry; Paul L Hebert; Ann M O'Hare Journal: JAMA Intern Med Date: 2019-03-01 Impact factor: 21.873
Authors: Catherine R Butler; Elizabeth K Vig; Ann M O'Hare; Chuan-Fen Liu; Paul L Hebert; Susan P Y Wong Journal: J Gen Intern Med Date: 2019-10-25 Impact factor: 5.128
Authors: Alycia A Bristol; Sobaata Chaudhry; Dana Assis; Rebecca Wright; Derek Moriyama; Katherine Harwood; Abraham A Brody; David M Charytan; Joshua Chodosh; Jennifer S Scherer Journal: Am J Hosp Palliat Care Date: 2021-01-13 Impact factor: 2.500